Ghent, Belgium – 10 February 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease, heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback